Evidence map›Paper›PMID 30474547›Full record

Observational studyBMC family practice2018

Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study.

Elzbieta Kaszuba, Håkan Odeberg, Lennart Råstam, Anders Halling

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMC family practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Muscle sympathetic nerve activity in COPD: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Further Developments towards a Minimal Potent Derivative of Human Relaxin-2.International journal of molecular sciences · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk.International journal of chronic obstructive pulmonary disease · 2020
    Observational
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elzbieta KaszubaSamaritens Primary Health Care Centre, 374 80, Karlshamn, Sweden. elzbieta.kaszuba@med.lu.se.ORCID 0000-0001-9808-6604
Håkan OdebergDepartment of Clinical Sciences in Malmö General Practice, Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden.
Lennart RåstamDepartment of Clinical Sciences in Malmö General Practice, Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden.
Anders HallingDepartment of Clinical Sciences in Malmö General Practice, Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden.

Funding

Blekinge County Council 16453189 project code 7116Skåne County Council 4068
6 · The paper itself

Abstract

backgroundMultimorbidity has already become common in primary care and will be a challenge in the future. Primary care in Sweden participates to a great extent in the care of patients with two severe, chronic conditions: chronic obstructive pulmonary disease (COPD) and heart failure. Both conditions are characterized by high mortality and often coexist. Age, sex, heart failure and other comorbidities are considered to be the major predictors of mortality in patients with COPD. We aimed to study the impact of heart failure, other comorbidities, age and sex on mortality in patients with COPD.

methodsA register-based, prospective cohort study conducted in Blekinge County in Sweden with about 150,000 inhabitants. The study population was comprised of people aged ≥35 years. The data about diagnoses of COPD and heart failure came from the 2007 health care register, in which we found 984 individuals with a diagnosis of COPD. Date of death was collected from January 1st, 2008 -August 31st, 2015. The diagnosis-based Adjusted Clinical Groups (ACG) Case-Mix System 7.1 was used to describe comorbidity. Each individual was assigned one of six comorbidity levels called resource utilization bands (RUB) graded from 0 to 5.

resultsEstimated eight year mortality in patients with COPD and coexisting heart failure was seven times higher than in patients with COPD alone - odds ratio 7.06 (95% CI 3.88-12.84). Adjusting for age and male sex resulted in odds ratio 3.75 (95% CI 1.97-7.15). Further adjusting for other comorbidities resulted in odds ratio 3.26 (95% CI 1.70-6.25). The mortality was strongly associated with the highest comorbidity level - RUB 5 where the odds ratio was 5.19 (95% CI 2.59-10.38).

conclusionHeart failure has an important impact on mortality in patients with COPD. The mortality in patients with COPD and coexisting heart failure was strongly associated with age, male sex and other comorbidities. Of those three predictors, only other comorbidities can be influenced. Heart failure and other comorbidities should be recognized early and properly treated in order to improve survival in patients with coexisting COPD and heart failure.

Indexed as

RegistriesAdultAgedAged, 80 and overCause of DeathComorbidityFemaleFollow-Up StudiesHeart FailureHumansMaleMental DisordersMiddle AgedOdds RatioPrimary Health CareProspective StudiesAgeChronic obstructive pulmonary diseaseComorbidityHeart failureMortalitySex

Identifiers

PMID30474547
PMCPMC6260666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.